IDSA Response to CDC’s Recommendation for People Previously Infected with COVID-19 to get Vaccinated

The Infectious Diseases Society of America strongly supports the CDC’s recommendation that unvaccinated people previously infected with the virus that causes COVID-19 get vaccinated as soon as possible after they have fully recovered.

Response to ACIP Recommendation for Heterologous Boosters

The Infectious Diseases Society of America supports the CDC Advisory Committee on Immunization Practice’s unanimous recommendation to allow “mix-and-match”—or heterologous—COVID-19 booster shots for at-risk populations. 

IDSA and HIVMA Support BIO Preparedness Workforce Act

IDSA and HIVMA applaud the bipartisan introduction of the Bolstering Infectious Outbreaks (BIO) Preparedness Workforce Act by Reps. Lori Trahan (D-MA) and David McKinley (R-WV), H.R. 5602, and its inclusion in an Oct. 26 Energy and Commerce Health Subcommittee hearing. 

IDSA Dismissed from Lawsuit Judge Rules Lawsuit Against IDSA Baseless

In legal rulings issued on Sept. 1 and Sept. 20, a federal judge in Texas dismissed all claims a group of Lyme disease patients had brought against the Infectious Diseases Society of America.  

Drug-resistant Infections Led to $1.9 Billion in Health Care Costs, More Than 10,000 Deaths Among Older Adults in One Year

Infections caused by bacteria resistant to multiple antibiotics led to $1.9 billion in health care costs, more than 400,000 days in the hospital and more than 10,000 deaths among older adults across the U.S. in 2017, according to a new study published today in Clinical Infectious Diseases.

IDSA Awarded Second CDC Grant for Continued COVID-19 Support for Health Care Workers

IDSA and the Centers for Disease Control and Prevention have announced they will continue their collaborative effort to support frontline health care professionals caring for patients with COVID-19.

Statement on Resignation of NIH Director Francis Collins

Dr. Collins has provided a steady, scientific voice throughout the COVID-19 pandemic. Under his leadership, NIH was instrumental in researching, developing and communicating about lifesaving COVID-19 vaccines and treatments. 

Clinical Considerations in Caring for Individuals Recently Returning and Evacuated from Afghanistan to the United States

IDSA, PIDS and SHEA recommend, in collaboration with the U.S. Centers for Disease Control and Prevention, that clinicians caring for these evacuees consider the varied presentations of medical conditions, including infectious diseases.

New Journal of Infectious Diseases Supplement Spotlights Vaccination Triumphs and Remaining Challenges

A special collection of new articles published in The Journal of Infectious Diseases highlights the great benefits to human health achieved by the development and use of vaccines.

IDSA Provides Comments to the National Quality Forum Patient Safety Standing Committee on the Severe Sepsis and Septic Shock: Early Management Bundle

IDSA has stated its opposition to the National Quality Forum’s re-endorsement of the Severe Sepsis and Septic Shock: Early Management Bundle (SEP-1) quality measure, as the Society has major concerns with the SEP-1 measure as it is currently specified.

Study Shows Black Women with HIV Had Highest Rates of Premature Mortality Between 1998-2018

Researchers at Vanderbilt University Medical Center found that despite improvements in mortality rates among people with HIV over 20 years, women had a higher risk of mortality than men, and Black women had the highest years of potential life lost, according to a study presented at IDWeek.

IDSA Recognizes Leading Infectious Diseases Experts

The Infectious Diseases Society of America is honoring 12 exemplary leaders in the field at IDWeek 2021. IDSA is pleased to recognize the following members for excellence in the field of infectious diseases: